Wave Life Sciences Ltd. announced executive changes. Keith C. Regnante resigned from his position as Chief Financial Officer effective as of January 9, 2020 in order to pursue other opportunities. He will assist with the transition of his responsibilities through January 31, 2020.

Company's Board of Directors appointed David Gaiero as Interim Chief Financial Officer, principal accounting officer and principal financial officer of the company, effective as of January 9, 2020,. He has served as Vice President, Corporate Controller of the Company since July 2017.